CEACAM5 expressed on intestinal epithelial cells (IECs) can bind with CD8α on CD8+ suppressor T cells, leading to the inhibition of CD8+ suppressor T cell activation and the increasing proliferation of CD4+ T cells in inflammatory bowel disease (IBD) patients (21, 22). Here, CEACAM5 is linked to inflammatory bowel disease.